These data suggest that Cl-IB-MECA-treated CD8+T cells are able to control tumor growth when adoptively transferred into melanoma-bearing mice and further support the concept that the anti-tumor activity of Cl-IB-MECA is mediated by CD8+ T cells. This evidence concerns the gene CD8A and melanoma.